The Na,K-pump, present in most cell membranes, is a biological system that moves K into and Na out of the cells. These movements are active, requiring a source of energy to transport Na and K against their concentration gradients. The operation of the pump maintains a low intracellular Na and high intracellular K, which contrasts with the concentration of these cations in the surrounding extracellular fluid. As a result of the pump function an electrical potential difference is created across the membrane, positive outside, negative inside. Many vital biological operations such as ionic movements, secretory functions, nerve conduction, and muscle contraction would be impossible without the efficient operation of the Na,K-pump.
The Na,K-pump is now generally accepted to be an enzyme, the Mg-dependent Na,K-adenosinetriphosphatase (Na,K-ATPase), which spans the width of the membrane. By a mechanism still not fully understood, conformational changes in the molecular structure of the enzyme translocate Na and K across the membrane. A variable but large number of pump units are located in the cell membrane. These pump units have a strong affinity for ouabain and other digitalis compounds, which readily attach to the enzyme and inhibit its activity. Thus, the pump units can also be regarded as receptors for ouabain and other digitalis compounds.
The efficiency of the Na,K-pump can be assessed in several ways. It can be measured by the ability of Na,K-ATPase to split ATP and release inorganic phosphate, by the capacity of the membrane to bind 3Houabain, by the rate of Na extrusion and K influx, by the intracellular Na content, and by the ratio between rate and Na content (rate constant). For technical reasons, most investigators substitute 86Rb for K in transport studies, since rubidium and potassium appear to be handled in identical fashion by the pump. It is fair to say that these various methods measure different, though interrelated, aspects of the pump function. A great deal of confusion in the literature can be ascribed to a loose reference to results ob-The International Journal Of Artificial Organs I Vol. 10 I n. 6, 1987 I pp. 346-348 tained by these methods as "pump function".
Since Welt first observed decreased red cell Na,K-ATPase activity in certain uremic patients (1), other investigators have examined pump function in different species and tissues. Despite some controversy, there is overwhelming evidence that the Na,K-pump is depressed in uremia. Thus, Na,K-ATPase activity is decreased in uremic red cells (1, 2), intestine (3), and brain (4). Chen et al. found decreased membrane 3Houabain binding -a technique that measures the number of pump sites -in the erythrocytes of uremic subjects (5), but other investigators found no differences in the number of pump sites (6) . The ouabain-inhibitable Na extrusion and K or Rb influx in erythrocytes and other cells has also been found reduced in uremia by many but not all investigators (7-11).
It is possible that a circulating factor may cause pump supression in uremia. This concept is supported by studies showing inhibition of the pump in normal erythrocytes incubated with uremic plasma (12), and by the observed improvement of pump-related transport after dialysis (6) . Although these findings are consistent with the presence of a circulating inhibitory substance in uremic plasma, they also pose important interpretational problems.
What is the mechanism of pump inhibition in uremia? According to one explanation, the toxins accumulated in uremia could inhibit the pump directly, Alternatively, it has been proposed that volume expansion may be responsible for inhibiting the pump. Na,K-ATPase or its functional parameters are depressed in several experimental forms of volume-expanded hypertension (13-16), as well as in human low-renin hypertension (17) . Diuretics, on the other hand, stimulate the pump (18) . These and other observations have led to the theory that volume expansion induces formation of a ouabain-like factor (OLF), probably produced in the hypothalamus (19, 20) . Certain OLF's, induced by volume expansion, which bind strongly to pump sites in the membrane in competition with ouabain, have recently been identified as nonesterified fatty acids (NEFA) and Iysophospholipids (21, 22) . It is, of course, possible that both accumulation of uremic toxins and the putative OLF induced by volume expansion may playa role in inhibiting the Na,K-pump in uremia.
Most studies of the Na,K-pump in uremia have been Quintanilla conducted in the erythrocyte, an anuclear cell which cannot synthesize enzymes. Although the evidence is controversial, it seems that cation-transport capacity of the uremic red cell membrane is impaired because of a reduced number of pump sites rather than because of decreased transport capacity (turnover rate) of each pump unit (5) . It is entirely possible, and consistent with differential studies of young and aged erythrocytes, that uremia reduces the synthesis of new pump units in the new erythrocytes, rather than eliminating already existent pumps in old erythrocytes. Long-term dialysis (> 3 weeks) increased the number of pumps in the uremic red cell whereas short-term (4 hours) did not. However, cation transport in some studies was improved by long-term (23) and even by short-term dialysis (6, 24) , this improvement correlating with fluid loss during dialysis. Thus it is possible that in addition to reduced number of pumps, a sluggishness of the pump, perhaps related to a dialyzable volume-dependent circulating factor, may be present in uremia (6) .
Regardless of the controversy over the mechanisms, inhibition of the Na,K-pump, demonstrated in a wide variety of tissues and species, may playa role in the genesis of uremic symptoms. To what extent is inhibition of the pump responsible for the protean manifestations of uremia? It is possible that the dysfunction of the nervous system, gastrointestinal tract, cardiovascular system, endocrine disorders, and the ill-defined lack of well-being experienced by these patients may be related to inhibition of the Na pump. This theory, attractive as it is, lacks convincing proof. Most likely, inhibition of the pump is at least in part responsible for some of the symptoms of uremia, but the exact extent of the role of Na,K-pump dysfunction in the genesis of uremic symptoms is yet to be established. 
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